This page shows the latest OPMD news and features for those working in and with pharma, biotech and healthcare.
That was followed swiftly by a $10m upfront deal with Benitec Biopharma for rights to a preclinical stage gene therapy for rare disease oculopharyngeal muscular dystrophy (OPMD), due to start trials
According to Axovant, patients with OPMD develop swallowing difficulties that can have potentially life-threating consequences, including malnutrition and aspiration pneumonia. ... I am excited about the potential of this platform for patients suffering
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...